Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial histone-like protein HU is a small, basic, and highly conserved nucleoid-associated protein (NAP) that plays a fundamental role in the architectural organization of the bacterial genome [1, 7, 12]. It functions by binding to double-stranded DNA, particularly at distorted sites such as nicks, gaps, and kinks, where it induces significant DNA bending and compaction to fit the chromosome within the cell [4, 5, 17]. Beyond its structural duties, HU is a critical regulator of essential cellular processes, including DNA replication initiation, recombination, repair, and the transcription of genes involved in stress response and virulence [12, 16]. In several major pathogens, including Mycobacterium tuberculosis and Streptococcus pneumoniae, HU is essential for survival, positioning it as a promising target for the development of novel antibiotics [1, 3, 16]. Therapeutic strategies targeting HU focus on small molecules, such as stilbene derivatives and epigallocatechin gallate (EGCG), which disrupt its ability to bind DNA and consequently collapse the nucleoid structure [1, 2]. Additionally, HU has been identified as a molecular glue that stabilizes the extracellular DNA matrix in bacterial biofilms, suggesting that its inhibition could also impair biofilm-mediated antibiotic resistance [2, 15]. While HU is structurally distinct from eukaryotic histones, a primary challenge in drug development is ensuring high specificity to avoid potential cross-reactivity with human DNA-binding proteins [3, 5]. Ongoing research continues to explore HU's role in host-pathogen interactions and its potential as a broad-spectrum antimicrobial target [2, 10].
Inhibition of DNA binding and compaction, leading to disruption of nucleoid architecture, impairment of chromosome segregation, and attenuation of bacterial virulence or biofilm integrity [1, 2, 3, 15].
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial histone-like protein HU (HU).